Similar Items: Evaluating Analytic Approaches to Determining Respiratory Syncytial Virus Seasonality—United States, 2014–2024
- Correlations and Timeliness of Respiratory Syncytial Virus Surveillance Indicators—United States, 2018–2024
- Reduction in Respiratory Syncytial Virus (RSV)‐Related Outpatient and Inpatient Cases Among Infants During the Initial 2024/2025 Season Following Nirsevimab Recommendation in Germany
- A Study on Clinical Features of Respiratory Syncytial Virus in Acute Respiratory Tract Infection in Elderly Hospitalized Patients in Winter
- Respiratory Syncytial Virus Transmission in Closed Community Settings That Include Children: A Systematic Review and Meta‐Analysis
- Correction to “Effectiveness of Influenza Vaccines in Italy in the 2024/2025 Season: A Nationwide, Test‐Negative Design Study Based on Surveillance Records”
- Correction to “Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024‐2025 Winter Season.”